From Cannabis MSO To Drug Development: Goodness Growth Wants To Understand Traditional Psychedelics Use

Resurgent Biosciences, a subsidiary of Goodness Growth Holdings, Inc. (CSE: GDNS) (OTCQX: GDNSF), is launching a study that will look into the varying effects of entheogen and psychedelic experiences for therapeutic, religious and spiritual purposes.

The goal of the company is to understand the naturalistic use of entheogens and other substances typically used for healing in specific cultural and spiritual contexts.

Goodness Growth recently changed its name from Vireo Health in a move to encompass the psychedelics and natural medicine space, expanding beyond its cannabis MSO operations.

A Into Traditional Psychedelics Use

The study’s approach seeks to complement …

Full story available on Benzinga.com

More From Cannabis MSO To Drug Development: Goodness Growth Wants To Understand Traditional Psychedelics Use